Literature DB >> 7119453

A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies.

A H Goodall, F L Meek, J A Waters, G C Miescher, G Janossy, H C Thomas.   

Abstract

A two-site antigen assay for HBsAg has been developed that employs 3 monoclonal antibodies. The antibodies were selected for their high affinity and their particular epitope specificity to establish an assay with a sensitivity for the antigen comparable with that of a conventional assay with heterologous antisera. In addition, by selecting a monoclonal antibody for use as a tracer which does not compete for antigenic binding sites with the solid-phase monoclonal antibodies, it has been possible to perform a two-site assay in a single 1 h incubation step, achieving the same degree of sensitivity. This principle of using monoclonal antibodies in a one-step assay therefore gives advantages of speed and simplicity over assays using heterologous antisera and would be applicable to a variety of antigen assays for which appropriate monoclonal antibodies are available.

Mesh:

Substances:

Year:  1982        PMID: 7119453     DOI: 10.1016/0022-1759(82)90042-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Monoclonal antibodies to human factor VII: production of immunodepleted plasma for VII:C assays.

Authors:  T Takase; E G Tuddenham; S Chand; A H Goodall
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

2.  Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

Authors:  I V Weller; A S Lok; A Mindel; P Karayiannis; S Galpin; J Monjardino; S Sherlock; H C Thomas
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

3.  Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major.

Authors:  B Wonke; A V Hoffbrand; D Brown; G Dusheiko
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

4.  Antigenic analysis of woodchuck hepatitis virus surface antigen with site-specific radioimmunoassays.

Authors:  P J Cote; R E Engle; C A Langer; A Ponzetto; J L Gerin
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

Authors:  M G Brook; J A McDonald; P Karayiannis; L Caruso; G Forster; J R Harris; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

6.  HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.

Authors:  K Tenner-Racz; P Racz; M Bofill; A Schulz-Meyer; M Dietrich; P Kern; J Weber; A J Pinching; F Veronese-Dimarzo; M Popovic
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

7.  Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.

Authors:  M G Brook; G Chan; I Yap; P Karayiannis; A M Lever; M Jacyna; J Main; H C Thomas
Journal:  BMJ       Date:  1989-09-09

8.  In vitro and in vivo cytotoxic activity of native and ricin conjugated monoclonal antibodies to HBs antigen for Alexander primary liver cell carcinoma cells and tumours.

Authors:  J M Oladapo; A H Goodall; R de Koning; J Parmar; D Brown; H C Thomas
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

9.  Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response.

Authors:  G Chen; P Karayiannis; M J McGarvey; A M Lever; J A McDonald; L J Scully; S Kanatakis; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

10.  Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.

Authors:  M A Aldouri; B Wonke; A V Hoffbrand; D M Flynn; M Laulicht; L A Fenton; P J Scheuer; C C Kibbler; C A Allwood; D Brown
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.